Combining DTI and MRI for the automated detection of alzheimer’s disease using a large european multicenter dataset

  • Authors:
  • Martin Dyrba;Michael Ewers;Martin Wegrzyn;Ingo Kilimann;Claudia Plant;Annahita Oswald;Thomas Meindl;Michela Pievani;Arun L. W. Bokde;Andreas Fellgiebel;Massimo Filippi;Harald Hampel;Stefan Klöppel;Karlheinz Hauenstein;Thomas Kirste;Stefan J. Teipel

  • Affiliations:
  • German Center for Neurodegenerative Diseases (DZNE), Rostock, Germany, Mobile Multimedia Information Systems Group (MMIS), University of Rostock, Rostock, Germany;Department of Radiology, University of California, San Francisco, USA, Center for Imaging of Neurodegenerative Diseases, VA Medical Center, San Francisco;German Center for Neurodegenerative Diseases (DZNE), Rostock, Germany;German Center for Neurodegenerative Diseases (DZNE), Rostock, Germany;Department of Scientific Computing, Florida State University, Tallahassee;Institute for Informatics, Ludwig-Maximilians-Universität München, Munich, Germany;Institute for Clinical Radiology, Department of MRI, Ludwig-Maximilians-Universität München, Munich, Germany;LENITEM Laboratory of Epidemiology, Neuroimaging and Telemedicine, IRCCS, Centro San Giovanni di Dio, FBF, Brescia, Italy;Cognitive Systems Group, Discipline of Psychiatry, School of Medicine, Trinity College Dublin, Dublin, Ireland, Trinity College Institute of Neuroscience (TCIN), Trinity College Dublin, Dublin, Ir ...;Department of Psychiatry, University Medical Center of Mainz, Mainz, Germany;Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, Scientific Institute and University Vita-Salute San Raffaele, Milan, Italy;Department of Psychiatry, Goethe University, Frankfurt, Germany;Department of Psychiatry and Psychotherapy, Department of Neurology, Freiburg Brain Imaging, University Medical Center Freiburg, Freiburg, Germany;Department of Radiology, University of Rostock, Rostock, Germany;Mobile Multimedia Information Systems Group (MMIS), University of Rostock, Rostock, Germany;German Center for Neurodegenerative Diseases (DZNE), Rostock, Germany, Department of Psychiatry, University of Rostock, Rostock, Germany

  • Venue:
  • MBIA'12 Proceedings of the Second international conference on Multimodal Brain Image Analysis
  • Year:
  • 2012

Quantified Score

Hi-index 0.00

Visualization

Abstract

Diffusion tensor imaging (DTI) allows assessing neuronal fiber tract integrity in vivo to support the diagnosis of Alzheimer's disease (AD). It is an open research question to which extent combinations of different neuroimaging techniques increase the detection of AD. In this study we examined different methods to combine DTI data and structural T1-weighted magnetic resonance imaging (MRI) data. Further, we applied machine learning techniques for automated detection of AD. We used a sample of 137 patients with clinically probable AD (MMSE 20.6 ±5.3) and 143 healthy elderly controls, scanned in nine different scanners, obtained from the recently created framework of the European DTI study on Dementia (EDSD). For diagnostic classification we used the DTI derived indices fractional anisotropy (FA) and mean diffusivity (MD) as well as grey matter density (GMD) and white matter density (WMD) maps from anatomical MRI. We performed voxel-based classification using a Support Vector Machine (SVM) classifier with tenfold cross validation. We compared the results from each single modality with those from different approaches to combine the modalities. For our sample, combining modalities did not increase the detection rates of AD. An accuracy of approximately 89% was reached for GMD data alone and for multimodal classification when GMD was included. This high accuracy remained stable across each of the approaches. As our sample consisted of mildly to moderately affected patients, cortical atrophy may be far progressed so that the decline in structural network connectivity derived from DTI may not add additional information relevant for the SVM classification. This may be different for predementia stages of AD. Further research will focus on multimodal detection of AD in predementia stages of AD, e.g. in amnestic mild cognitive impairment (aMCI), and on evaluating the classification performance when adding other modalities, e.g. functional MRI or FDG-PET.